Source: National Law Review

National Law Review reports on a Patent Trial and Appeal Board (PTAB) decision rejecting a patent application for an AI-driven medical invention due to lack of novelty and eligibility. The article examines legal standards and challenges in patenting AI-generated innovations.

It analyzes the case, discusses implications for medical AI research, and offers recommendations for applicants seeking patents involving AI. The piece reviews evolving jurisprudence and balances innovation incentives with strict patentability criteria. It highlights future trends in AI-related medical patents.